WEE1 and neoplasm: Recent studies have found that ATRX alterations contribute to immune escape and increased tumor growth in pleomorphic sarcoma and that ATRX-deficient tumor cells were particularly susceptible to the WEE1 inhibitor AZD1775 [28,29].